Watabe, Tadashi https://orcid.org/0000-0001-8658-2395
Hatano, Koji
Naka, Sadahiro
Sasaki, Hidetaka
Kamiya, Takashi
Shirakami, Yoshifumi
Toyoshima, Atsushi
Cardinale, Jens
Giesel, Frederik L.
Isohashi, Kayako
Nonomura, Norio
Tomiyama, Noriyuki
Funding for this research was provided by:
Osaka University
Article History
Received: 8 November 2024
Accepted: 2 December 2024
First Online: 17 December 2024
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the institutional review board of Osaka University Hospital (approval number: 239012-A).
: Written informed consent was obtained from the patient.
: FLG is an advisor at ABX Radiopharmaceuticals, SOFIE Biosciences, Telix Pharma, and Alpha Fusion. FLG holds shares in a consultancy group for iTheranostics. The other authors declare no potential conflicts of interest relevant to this study.